Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline ProgressUnusual Whales·Aug 5 at 03:17 PMCNTX-6.55%
Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business UpdateUnusual Whales·Aug 5 at 06:55 AMKYMR+0.99%
Kindred Companion Sciences Unveils First Dogs Genetically Edited to Remove the Major Dog AllergenUnusual Whales·Aug 5 at 06:08 AM
SAFETY SHOT INC C/WTS 30/10/2025(TO PUR COM) | 10-Q: FY2025 Q2 Revenue: USD 44.95 KEarnings Watch·Aug 14, 2025 at 04:17 PMSHOTW0.00%BNKKW0.00%
SAFETY SHOT INC C/WTS 30/10/2025(TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 42.1 KEarnings Watch·May 15, 2025 at 03:02 PMSHOTW0.00%BNKKW0.00%
